ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1228

Prescribing for Children with Rheumatologic Disease: Differences Between Pediatric and Adult Rheumatologists

Heather Van Mater1, Stephen Balevic2, Gary Freed3 and Sarah J. Clark4, 1Pediatrics/ Pediatric Rheumatology, Duke University Medical Center, Durham, NC, 2Rheumatology/Pediatric Rheumatology, Duke University Medical Center, Durham, NC, 3University of Michigan Health System, Ann Arbor, MI, 4Pediatrics & Communicable Diseases, University of Michigan Health System, Ann Arbor, MI

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: juvenile idiopathic arthritis (JIA) and prescribing trends

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Health Services Research - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Rheumatologic diseases affect 300,000 children in the United States and are associated with significant morbidity.1,2  Due to a national shortage of pediatric rheumatologists (PR),2 an estimated half of US children with rheumatologic disease are being cared for by adult rheumatologists (AR).2,3 However, many AR report being uncomfortable caring for children and do not perceive themselves as up to date.4  How variations in treatment relate to subspecialty, fellowship training, and information resources are not known.

Methods:  Two parallel, cross sectional mail surveys with a focus on juvenile idiopathic arthritis (JIA) were administered to a random sample of 193 PR and 500 AR using the American College of Rheumatology membership file. Bivariate analysis was conducted for items common to both surveys.  

Results: The response rate was 62.1% for AR (N=306) and 72.3% for PR (N=138).   Only 23% of responding AR (N=69) reported caring for children with JIA. Of these, 94% strongly agreed/agreed that they are comfortable diagnosing JIA; however, only 76% report being comfortable treating JIA. Clinical vignettes highlighted several prescribing differences (Table 1).  Forty-eight percent of AR, and 31% of PR, felt medications to treat JIA did not have clear dosing guidelines. Though PR initiated DMARDs and biologics earlier, after three months the selected treatments for JIA were quite similar. Co-management of JIA patients by adult and pediatric rheumatologists is infrequent and its acceptance seems limited.  

Conclusion: Nearly a quarter of surveyed adult rheumatologists care for children with JIA, with most limiting their practice to older children. There was more discomfort in treating JIA than diagnosing it, and there were significant prescribing differences.  Both adult and pediatric providers reported a lack of adequate dosing/treatment resources.  Easily accessible and up-to-date treatment and dosing guidelines, as well as exposure to pediatric rheumatology in fellowship, would further enhance the care of children with JIA and facilitate collaboration between adult and pediatric providers.   1.  Sacks JJ. Helmick CG. Luo YH. Ilowite NT. Bowyer S. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. Arthritis Rheum. 2007; 57(8): 1439-1445. 2. Duke EM. Report to Congress. The Pediatric Rheumatology Workforce: A Study of the Supply and Demand for Pediatric Rheumatologists. http://bhpr.hrsa.gov/healthworkforce/reports/ped_rheumatology/ 3. Mayer ML, Sandborg CI and Mellins ED. Role of pediatric and internist rheumatologists in treating children with rheumatic diseases. Pediatrics 2004; 113(3): 173-181. 4. Sherry DD, Wallace CA, Kahn S. Pediatric rheumatology in adult rheumatology practices in Washington State. Arthritis Rheum. 1996; 39(7):1218-1221.


Disclosure: H. Van Mater, None; S. Balevic, None; G. Freed, None; S. J. Clark, None.

To cite this abstract in AMA style:

Van Mater H, Balevic S, Freed G, Clark SJ. Prescribing for Children with Rheumatologic Disease: Differences Between Pediatric and Adult Rheumatologists [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/prescribing-for-children-with-rheumatologic-disease-differences-between-pediatric-and-adult-rheumatologists/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prescribing-for-children-with-rheumatologic-disease-differences-between-pediatric-and-adult-rheumatologists/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology